Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions-Reference-Cited by-同舟云学术

Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions

Published:2017-06-27 Issue:8 Volume:10 Page:631-645
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Lambert Aurélien¹,Gavoille Céline¹,Conroy Thierry²

Affiliation:

1. Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France

2. Department of Medical Oncology and Université de Lorraine, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne, CS 30511, 54511 Vandœuvre-lès-Nancy, France

Publisher

SAGE Publications

Subject

Gastroenterology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756283X17713879

Reference68 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. Cancer statistics, 2017

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

4. Analysis of Response-Related and Time-to-event Endpoints in Randomized Trials of Gemcitabine-Based Treatment Versus Gemcitabine Alone as First-Line Treatment of Patients With Advanced Pancreatic Cancer

5. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology;Expert Opinion on Drug Delivery;2024-06-02

2. Evaluation of the Treatment Duration of Japanese Patients With Pancreatic Cancer in a Real-World Setting Using a Large Hospital Claims Database;Pancreas;2024-05-16

3. Irinotecan dosing and pharmacogenomics: a comprehensive exploration based on UGT1A1 variants and emerging insights;Journal of Chemotherapy;2024-05-06

4. Co-delivery of epirubicin and letrozole using a metal-organic framework nanoparticle in breast cancer therapy;Journal of Drug Delivery Science and Technology;2024-05

5. Percutaneous Treatment of Hydatid Cysts with the Ormeci Technique;TURK J GASTROENTEROL;2024